Ayala Pharmaceuticals (CE) Stock Quote ADXS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.027

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

0.0012 52 Week Range 1.49

Market Cap

1.151M

Previous Close

0.027

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,390

Shares Outstanding

42,633,400

Dividend Yield

PE Ratio

-0.03

Earnings Per Share (EPS)

-1.13

Revenue

13k

Net Profit

-48.07M

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Ayala's approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer ... Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Ayala's approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. The company has two product candidates under development, AL101 and AL102, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors including Adenoid Cystic Carcinoma (ACC), T-cell Acute Lymphoblastic Leukemia (T-ALL), and Desmoid Tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ayalapharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Ayala Pharmaceuticals Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ADXS. The last closing price for Ayala Pharmaceuticals (CE) was $0.03. Over the last year, Ayala Pharmaceuticals (CE) shares have traded in a share price range of $ 0.0012 to $ 1.49.

Ayala Pharmaceuticals (CE) currently has 42,633,400 shares outstanding. The market capitalization of Ayala Pharmaceuticals (CE) is $1.15 million. Ayala Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of -0.03.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0781	-74.3101807802	0.1051	0.1051	0.027	1205	0.05750731	CS
4	0	0	0.027	0.1051	0.027	1352	0.03687377	CS
12	0.007	35	0.02	0.1051	0.02	1390	0.04522291	CS
26	-0.273	-91	0.3	0.3196	0.0012	4511	0.18415941	CS
52	-0.763	-96.582278481	0.79	1.49	0.0012	11795	0.7146646	CS
156	-4.963	-99.4589178357	4.99	4.99	0.0012	158894	0.17609312	CS
260	-0.108	-80	0.135	4.99	0.0012	157499	0.17609312	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AABVFAberdeen International Inc (PK)	$ 0.0284 (0.00%)	0
AABKFAareal Bank AG (PK)	$ 0.00 (0.00%)	0
AABBAsia Broadband Inc (PK)	$ 0.0228 (0.00%)	0
AAALYAareal Bank AG (PK)	$ 34.65 (0.00%)	0
AAAIFAlternative Investment Trust (PK)	$ 0.55 (0.00%)	0
AABVFAberdeen International Inc (PK)	$ 0.0284 (0.00%)	0
AABKFAareal Bank AG (PK)	$ 0.00 (0.00%)	0
AABBAsia Broadband Inc (PK)	$ 0.0228 (0.00%)	0
AAALYAareal Bank AG (PK)	$ 34.65 (0.00%)	0
AAAIFAlternative Investment Trust (PK)	$ 0.55 (0.00%)	0
AABVFAberdeen International Inc (PK)	$ 0.0284 (0.00%)	0
AABKFAareal Bank AG (PK)	$ 0.00 (0.00%)	0
AABBAsia Broadband Inc (PK)	$ 0.0228 (0.00%)	0
AAALYAareal Bank AG (PK)	$ 34.65 (0.00%)	0
AAAIFAlternative Investment Trust (PK)	$ 0.55 (0.00%)	0